imatinib mesylate has been researched along with Hermanski-Pudlak Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandara, G; Cruse, G; Desai, A; Fischer, ER; Gahl, WA; Gochuico, BR; Kirshenbaum, AS; Lee, CC; Leerkes, M; Metcalfe, DD; O'Brien, KJ; Stone, K | 1 |
| Azuma, A | 1 |
1 review(s) available for imatinib mesylate and Hermanski-Pudlak Syndrome
| Article | Year |
|---|---|
[Expectation of new treatments for idiopathic interstitial pneumonias].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Clinical Trials as Topic; Hermanski-Pudlak Syndrome; Humans; Imatinib Mesylate; Interferon-gamma; Lung; Middle Aged; Piperazines; Prognosis; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyridones; Pyrimidines; Survival Analysis | 2005 |
1 other study(ies) available for imatinib mesylate and Hermanski-Pudlak Syndrome
| Article | Year |
|---|---|
Immunophenotypic and Ultrastructural Analysis of Mast Cells in Hermansky-Pudlak Syndrome Type-1: A Possible Connection to Pulmonary Fibrosis.
Topics: Adult; Biomarkers; Case-Control Studies; Cell Line; Cells, Cultured; Chemotaxis; Cluster Analysis; Extracellular Matrix; Female; Gene Expression Profiling; Hermanski-Pudlak Syndrome; Humans; Imatinib Mesylate; Immunophenotyping; Lung; Male; Mast Cells; Membrane Proteins; Middle Aged; Mutation; Phenotype; Pulmonary Alveoli; Pulmonary Fibrosis; Young Adult | 2016 |